Masitinib
Drug timelines are a Plus or Pro feature.
32 regulatory and trial events tracked for Masitinib, covering 2018-12-10 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Masitinib in Patients With Mild Alzheimer's Disease [Phase 3]